Catalyst Wire Dossier Catalyst Wire Dossier

Telbivudine

telbivudine · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

45 regulatory and trial events tracked for Telbivudine, covering 2009-04-20 to 2019-09-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection [Phase 3]

See pricing